DEFA14A ·Filed Apr 24, 2026

IMNM

Immunome Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001140361-26-016689
Proxy solicitation materials
Actionable Insight • Neutral

This is a routine proxy filing with no material changes. Monitor for any unexpected developments in the actual proxy materials, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
IMNM ▼ -2.60% at T+60d
NEUTRAL call ✗ call lost -2.60% · α vs SPY -7.37% · entry $23.49 → $22.88
Entry anchored
Apr 24, 03:59 PM ET
via exchange tick
T+1d
+0.94%
call +0.94% · α +1.42%
$23.71
settled 5mo ago
T+5d
-0.68%
call -0.68% · α -1.08%
$23.33
settled 5mo ago
T+20d
-6.73%
call -6.73% · α -11.68%
$21.91
settled 4mo ago
T+60d
-2.60%
call -2.60% · α -7.37%
$22.88
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Immunome Inc. filed a definitive proxy statement (DEFA14A) for an upcoming shareholder meeting, which includes routine matters such as director elections and executive compensation. The filing is standard and does not contain any activist demands, merger proposals, or unexpected corporate actions. Market data shows recent insider selling activity, but no significant changes in analyst sentiment.

Key Facts

  • Routine proxy filing for shareholder meeting
  • No activist campaign or merger proposal
  • Standard agenda items: director elections and executive compensation
  • Recent insider selling of $1.6M vs $501K in buys
  • 95% bullish analyst sentiment with 19 buy ratings

Financial Impact

No immediate financial impact

revenueepsdilution

Risk Factors

  • Potential for unexpected developments in full proxy materials
  • Insider selling could indicate lack of confidence

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-016689
Document: 0001140361-26-016689-index-headers.html0001140361-26-016689
Document: 0001140361-26-016689-index.html0001140361-26-016689
Document: 0001140361-26-016689.txt0001140361-26-016689
13 reports for IMNM
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+60▲ +26.53%May 28, 2026
Filters
Rows
Reports for IMNM — sortable, filterable
TypeNow
Oct 1, 2026
1d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$21.58 awaiting T+5awaiting T+5—$20.97 (−2.85%)
Sep 21, 2026
11d ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$25.07 $21.68▼ −13.52%▼ −13.24%$20.97 (−16.37%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$26.42 $28.08▲ +6.28%▲ +8.25%$20.97 (−20.65%)
Aug 10, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$26.25 $27.56▲ +4.99%▲ +5.39%$20.97 (−20.13%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$23.35 $22.20▼ −4.93%▼ −4.36%$20.97 (−10.21%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 4/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 7, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.01 $22.59▼ −5.91%▼ −6.78%$20.97 (−12.68%)
Jul 3, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$23.61 $24.17▼ −2.37%▼ −1.44%$20.97 (+11.20%)
May 28, 2026
18w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$22.54 $19.81▼ −12.11%▼ −12.06%$20.97 (−6.99%)
May 12, 2026
20w ago
8-K
BULLISH ★ 7/10
$22.20 $19.66▼ −11.44%▼ −10.28%$20.97 (−5.56%)
Showing 10 of 13

US Market Status

Market Open — Closes in 51m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access